Atria Investments’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,473
Closed -$51.8K 2136
2026
Q1
$51.8K Buy
20,473
+8,476
+71% +$21.7K ﹤0.01% 2024
2025
Q4
$40.1K Buy
+11,997
New +$42.7K ﹤0.01% 2017
2025
Q3
Sell
-12,849
Closed -$55.3K 2033
2025
Q2
$55.3K Buy
12,849
+608
+5% +$2.45K ﹤0.01% 1976
2025
Q1
$48.1K Buy
+12,241
New +$58K ﹤0.01% 1883
2024
Q4
Sell
-10,923
Closed -$77.6K 1872
2024
Q3
$77.6K Sell
10,923
-120
-1% -$765 ﹤0.01% 1879
2024
Q2
$62.8K Buy
+11,043
New +$70.4K ﹤0.01% 1887

Other funds holding CLVT

Atria Investments's CLVT Position: Q2 2026 in Review

Atria Investments sold out of Clarivate (CLVT) in Q2 2026, closing a stake of 20,473 shares — an estimated $51.8K sold.

Atria Investments first reported a position in CLVT in Q2 2024 and held it in 6 quarters. The position peaked at $77.6K in Q3 2024. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • Atria Investments reported no remaining Clarivate position as of Q2 2026 after selling out during the quarter.
  • Atria Investments sold 20,473 Clarivate shares in Q2 2026, an estimated $51.8K.
  • Atria Investments first reported a position in Clarivate in Q2 2024 and held it in 6 quarters.
  • Atria Investments's Clarivate position peaked at $77.6K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.